CYH33

1 paper studies it1 finding

Across all fields, 1 paper: none in people yet, 1 in animals

1 lab in 1 country

Animals1

Outcomes

1

Tumor growth

downin mice1

1 study

CYH33 decreases tumor growth in mice.
“CYH33 significantly inhibited tumor growth with a modest effect on glucose homeostasis.”
AnimalsID8 syngeneic murine ovarian cancer model
Dapagliflozin alleviates CYH33-induced hyperglycemia and preserves antitumor immunity against ovarian cancer in type 1 diabetic mice
Life sciencesOct 17, 2026

Latest

1 paper in 12 months

Life SciencesOct 18

Dapagliflozin alleviates CYH33-induced hyperglycemia and preserves antitumor immunity against ovarian cancer in type 1 diabetic mice

Experiments in miceDapagliflozin